Jeffrey J. Brown - Nov 3, 2023 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Nov 3, 2023
Transactions value $
$10,845
Form type
4
Date filed
11/9/2023, 08:19 PM
Previous filing
Oct 26, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Purchase $6.82K +96.7 +2.34% $70.55 4.23K Nov 3, 2023 Jeffrey Brown Living Trust F1, F2
transaction MED Common Stock Purchase $4.02K +58.4 +1.02% $68.89 5.78K Nov 7, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F2 These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.
F3 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.